Globenewswire

Published September 8, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling - GlobeNewswire

(Nasdaq: CMND) (the “Company” or “Clearmind”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic ... press release .

Read the full story at Globenewswire